Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing 
How Braden Business Systems Use Auvik SaaS Management
to Identify, Secure, and Manage SaaS Sprawl About Braden Business Systems & Jon Fitzryk Since 1989, Braden Business Systems has...
Efficient Network Management: A Dive into Auvik Network Management’s Robust Features
In today's fast-paced digital world, efficient and effective network management has become more important than ever. With businesses relying heavily...
Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing
FORT LAUDERDALE, FL / ACCESS Newswire / May 28, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical...
Medical Care Technologies (OTC PINK:MDCE) Provides Additional Details Regarding MDCE Melanoma Scan Beta Imaging Platform
Company discusses AI-assisted body-map monitoring architecture and long-term imaging technology development initiatives MESA, AZ / ACCESS Newswire / May 28,...
Patient Safety Movement Foundation Appoints Three Distinguished Leaders to Governance Board
Global nonprofit strengthens leadership with expertise spanning government, medicine, and international healthcare systems in pursuit of zero preventable patient harm...
Aspire Biopharma Issues Shareholder Letter
ESTERO, FL / ACCESS Newswire / May 28, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a...
TRNR Updates Investor Presentation Detailing Acquisition Strategy and Increased M&A Pipeline
AUSTIN, TX / ACCESS Newswire / May 28, 2026 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of...
Black Book to Release 2026 Top Vendor Client Satisfaction Results Ahead of AHIP26 and HFMA Annual Conferences
Thousands of validated payer IT users and provider finance, business office, RCM and reimbursement professionals contribute category-specific evaluations across 90...
Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer
Experienced oncology R&D leader appointed to support Aptevo's expanding oncology pipeline and new radiopharmaceutical development strategy SEATTLE, WA / ACCESS...
Phase 1 Equity Announces Its Third Practice Addition of the Year, Bringing on a Multi-Site Orthodontic Practice Located in Texas
CHICAGO, IL / ACCESS Newswire / May 28, 2026 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for...
Wellgistics Health Announces Lock-Up Agreement with Holders of a Majority of its Common Stock
Holders of 1,333,930 common shares agree to minimum 90-day lock-up agreement TAMPA, FL / ACCESS Newswire / May 28, 2026...
Protagonist Therapeutics to Participate in Two Investment Bank Conferences in June 2026
NEWARK, CA / ACCESS Newswire / May 28, 2026 / Protagonist Therapeutics (Nasdaq:PTGX) ("Protagonist" or "the Company") today announced that...
Dr. David Pincus of Pincus Plastic Surgery Educates Patients on Choosing Between Implants and Fat Transfer for Breast Enhancement
A Clearer Path to Informed Aesthetic Decisions BOCA RATON, FL / ACCESS Newswire / May 28, 2026 / Board-certified plastic...
Syneos Health Appoints Greg Licholai as Chief Medical Officer to Advance Next-Generation Drug Development
Further Strengthens Company’s Medical Depth and Therapeutic ExpertiseMORRISVILLE, N.C., May 28, 2026 (GLOBE NEWSWIRE) -- Syneos Health®, a leading fully...
Entera’s EB613, First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis – Single Tablet Data Selected for Late Breaking Oral Presentation at ENDO 2026 Annual Meeting; Additional Oral Peptide Pipeline Data Accepted for Presentation
TEL AVIV, May 28, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in...
SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum
TEL AVIV, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs...
FOXO TECHNOLOGIES, INC., FORMS STRATEGIC PARTNERSHIP WITH LONGEVITYFP TECHNOLOGIES, LLC. TO COMMERCIALIZE FOXO’S EPIGENETICS TECHNOLOGY
WEST PALM BEACH, FL and MINNETONKA, MN, May 28, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC: FOXO) (the “Company”)...
Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
WAYNE, Pa., May 28, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing...
RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic Cancer
Third FDA Orphan Drug Designation Continues to Advance RenovoRx's Therapeutic Oncology Pipeline and Provides Seven Years of Market ExclusivityMOUNTAIN VIEW,...
Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial
PARAMUS, NJ, May 28, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics, Inc. (the “Company” or “Polaryx”) (Nasdaq: PLYX), a clinical-stage biotechnology...
Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
THE WOODLANDS, Texas, May 28, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate...
Vor Bio to Participate in the 2026 Jefferies Global Healthcare Conference
BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune...